A study evaluating effect of Sacubitril/Valsartan on endogenous intact (active) GLP-1 compared to valsartan in patients with type 2 diabetes or pre-diabetes and elevated blood pressure.
Phase of Trial: Phase IV
Latest Information Update: 23 Apr 2018
Price : $35 *
At a glance
- Drugs Sacubitril/valsartan (Primary) ; Valsartan
- Indications Hypertension; Prediabetic state; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 23 Apr 2018 New trial record
- 20 Mar 2018 Enrollment will begin in late 2017.
- 20 Mar 2018 Trial design presented at The 100th Annual Meeting of the Endocrine Society